Recent Headlines
SignaBlok Awarded DARPA Contract to Support New Technology to Combat Sepsis
SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to introduce company’s new approach to the prevention and treatment of sepsis (blood poisoning). - January 12, 2012 - SignaBlok, Inc.
Aciont® To Present on VisulexTM Technologies at the 4th Ocular & Drug Discovery Conference
Aciont Inc. announced today that both Kongnara Papangkorn, Research Director and Sarah Abdulla Molokhia, Scientific Research Consultant, will present on Aciont’s Visulex technologies at the Global Technology Community’s 4th Ocular & Drug Discovery Conference, February 27-28, 2012,... - January 12, 2012 - Aciont Inc.
Autoscribe Launches US Operation
The formation of Autoscribe Informatics Inc., a wholly owned subsidiary of Autoscribe Ltd, has been announced. Based in Falmouth, MA, USA, it gives Autoscribe, the developers of Matrix software products, a much stronger presence in the US and Canadian markets. Zumatrix Inc. operated as... - January 12, 2012 - Autoscribe Informatics
CrystalGenomics to Present at J.P. Morgan Healthcare Conference on January 12
CrystalGenomics, Inc. (KOSDAQ: CRYSTAL (083790)), a clinical stage biopharmaceutical company headquartered in Korea, has just announced that Joong Myung Cho, Ph.D., President & CEO, will present an overview of CrystalGenomics’ business strategy and an update on its development pipeline on... - January 11, 2012 - CrystalGenomics, Inc.
Declan Doogan of Amarin to Keynote CHI’s Conference on Phase III Clinical Trials
Amarin’s CMO to lead line-up of thought leaders at Cambridge Healthtech Institute’s executive and scientific forum. - December 26, 2011 - Cambridge Healthtech Institute
AnaSpec Highlights HiLyte Fluor™ Dyes Collection - for Labeling Amine and Thiol-Modified Oligos
AnaSpec is pleased to highlight their wide collection of amine and thiol reactive 6-isomeric dyes of fluoresceins and rhodamines, and AnaSpec’s own proprietary HiLyte Fluor™ dyes for labeling amine and thiol modified oligonucleotides. Fluorescent dye-labeled oligos are widely used as... - December 21, 2011 - AnaSpec, EGT Group
TransEnterix Closes $15M in Equity Financing
Second tranche of Series B to accelerate development and commercialization of new flexible surgical tools - December 18, 2011 - TransEnterix
New Lightning-Link® Rapid Antibody Labeling Kits Now for DyLight™ Dyes
The Lightning-Link® Rapid Antibody kits allow direct antibody labeling reactions to be set up in seconds and used within just 20 minutes. Novus has recently expanded their Lighting-Link® Rapid kits to include the following DyLight™ dyes. Lightning-Link® Rapid DyLight... - December 17, 2011 - Novus Biologicals
Novus New Lab Program - Receive 20% Off for New Labs
Novus Biologicals understands the funding constraints and logistical difficulties of starting a new lab. Therefore, Novus is proud to announce a New Lab Program, offering 20% off Novus purchases for your first 3 months. Additionally, Novus will provide a welcome kit full of useful tools for your... - December 16, 2011 - Novus Biologicals
Novus Products Now Available Through the UPENN Cell Center Stockroom
Novus is proud to announce that select products will now be available through the University of Pennsylvania’s Cell Center Stockroom. Researchers who order through the Cell Center Stockroom will receive a 20% discount off the regular list price and free shipping. The Cell Center Stockroom... - December 15, 2011 - Novus Biologicals
SFL’s Public Affairs Now Covers Bioethics
SFL’s Public Affairs team, helping organizations shape EU rules, saw exciting expansion in 2011. - December 11, 2011 - SFL Regulatory Affairs & Scientific Communication Ltd
SFL Thanks Clients and Partners for Successful Collaborations
With the end of 2011 approaching, SFL can reflect on a very successful year of extension and expansion in all areas. The company’s client base has expanded internationally as demand has grown for its personalized and comprehensive services in the fields of Regulatory Affairs, Public Affairs, Legal Services and Medical Communication. - December 08, 2011 - SFL Regulatory Affairs & Scientific Communication Ltd
Mitegen Announces Distribution Agreement with Helix Biotech in Malaysia
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed a distribution agreement with Helix Biotech (M) SDN BHD of... - November 12, 2011 - MiTeGen, LLC
Mitegen Announces Mutual Distribution Agreements with AJK Analytical Services
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed mutual distribution agreements with AJK Analytical Services. - November 12, 2011 - MiTeGen, LLC
Novus Biologicals Announces New ROBLD3 Antibody Made Using SDIX Genomic Antibody Technology™
Novus Biologicals announced today a new ROBLD3 antibody (catalog number NBP1-71687) for use in research on cell growth regulation. This ROBLD3 antibody was made using SDIX Genomic Antibody TechnologyTM. ROBLD3 is one of three individual proteins (ROBLD3, c11orf59 & MAPKSP1) that form the... - November 11, 2011 - Novus Biologicals
Introducing BioDatomics - the Latest Bioinformatics & Computational Biology Platform
BioDatomics releases a new version of their computational biology analysis and visualization platform – a workstation version is now available for free download. - November 10, 2011 - BioDatomics
RayBiotech, Inc. Engages Industry Expert for Business Development & Growth Advisory Services
RayBiotech, Inc., today announced that it has engaged recognized industry expert, David A. Dodd of RiversEdge BioVentures LLC to work with the Company in the areas of Business Development and Strategic Growth Opportunities. - November 10, 2011 - RayBiotech, Inc
Prevtec microbia Closes a $4 Million Financing Round with North-American and European Investors
Prevtec microbia inc., a rapidly expanding Canadian biotech company developing innovative animal health technologies for the livestock industry, announced that it has closed a $4 million financing round from a global syndicate of financial and industry leaders. The proceeds will mostly be used to... - November 09, 2011 - Prevtec microbia inc.
VP at OSO BioPharmaceuticals Elected to DCAT Board of Directors
Milton Boyer to serve three-year term at leading industry association. - November 03, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
Mitegen Announces Mutual Distribution Agreements with XTalQuest Inc., Ltd.
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed mutual distribution agreements with XTalQuest Inc., Ltd a Beijing based provider of high quality crystallization plates, screening solutions, and other products for crystallography. - November 01, 2011 - MiTeGen, LLC
Novus Biologicals Announces New CHD7 Antibody Made Using SDIX Genomic Antibody Technology™
Novus Biologicals announced today a new CHD7 antibody (catalog number NBP1-77393) for use in research on transcription regulation and CHARGE syndrome. This CHD7 antibody was made using SDIX Genomic Antibody TechnologyTM. CHD7 is an ATP-dependent chromatin remodeler that interacts closely with SOX2... - October 29, 2011 - Novus Biologicals
New LDL and VLDL Receptor Antibodies Released
Novus Biologicals announced today the release of new LDL Receptor (NBP1-78159) and VLDL Receptor (NBP1-78162) antibodies. LDL and VLDL Receptors are similar cell-surface receptor proteins which mediate endocytosis of cholesterol-rich lipoproteins. Both receptors are critical to the lipid and... - October 27, 2011 - Novus Biologicals
Novus Biologicals Announces New PAR1 Antibody
Novus Biologicals announced today a new Thrombin Receptor antibody (catalog number NBP1-71770) for use in wound healing and cancer research. Thrombin Receptor, also known as Protease activated receptor 1 (PAR1), is a G-protein-coupled receptor that functions in blood clotting. While Thrombin... - October 26, 2011 - Novus Biologicals
Novus Biologicals Announces New SHDA Antibody Made Using SDIX Genomic Antibody Technology™
Novus Biologicals announced today a new SDHA Antibody (catalog number NBP1-71688) for use in hypoxia research. This SHDA antibody was made using SDIX Genomic Antibody TechnologyTM. Localized within the mitochondrial inner membrane, Succinate Dehydrogenase A (SDHA) is an important component in the... - October 23, 2011 - Novus Biologicals
Advanced Cancer Therapeutics CEO to Present Preclinical Data on Cancer Metabolism Drug at MidAmerica Healthcare Venture Forum
Advanced Cancer Therapeutics, LLC (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that Randall B. Riggs, President & CEO, has been selected to present at the 9th Annual MidAmerica Healthcare Venture Forum to be held at the... - October 20, 2011 - Advanced Cancer Therapeutics
Novus Biologicals Announces New Dicer1 Antibody Made Using SDIX Genomic Antibody Technology™
Novus Biologicals announced today a new DICER1 antibody (catalog number NBP1-71691) for use in cell cycle and replication and cancer research. This DICER1 antibody was made using SDIX Genomic Antibody TechnologyTM. DICER1 is a ribonuclease that has been extensively shown to be related to cancer. - October 20, 2011 - Novus Biologicals
AnaSpec Introduces SensoLyte® Deubiquitination Assay Kit
AnaSpec, EGT Group, is pleased to introduce the SensoLyte® 440 Deubiquitination Assay Kit. This kit provides a convenient assay for inhibitors/activators screening in deubiquitinylation or for continuous assay of enzyme activity. A natural substrate, ubiquitin, coupled with the AMC... - October 19, 2011 - AnaSpec, EGT Group
AnaSpec Includes Citrullinated Histone in GO® Peptides Collection
AnaSpec, the world’s largest provider of on-demand GO® peptides is pleased to offer a wide selection of Histone H1, H2A, H2B, H3 and H4 peptides, especially the H3 peptides. The rapidly expanding Histone GO® Peptides now include citrullinated sequences in addition to sequences that... - October 19, 2011 - AnaSpec, EGT Group
Novus Focuses on Supplying Quality Antibodies for Model Organism Research
Novus is a leading supplier of research antibodies that have been validated for use in model organisms, and they have recently expanded their selection of top quality reagents for Drosophila melanogaster, Caenorhabditis elegans, and Xenopus laevis. These three model organisms are commonly used in... - October 15, 2011 - Novus Biologicals
MMS Announces Strategic Alliance with TransPerfect
MMS Holdings Inc. announces a strategic alliance with TransPerfect, the world's largest privately held provider of language services and technology, to offer translation and interpretation services to their clients across global clinical programs. These services are complimentary to those offered... - October 15, 2011 - MMS Holdings Inc.
Novus Announces Two Contest Winners
Novus Biologicals announced today the winners of two customer contests. First, the third quarter Novus Travel Grant winner is Dr. Toryn Poolman of the University of Manchester's School of Medicine, selected for his excellent review of our Glucocorticoid Receptor Antibody (NB300-610). Dr. Poolman... - October 14, 2011 - Novus Biologicals
New EpiPlus - Histone Modification Antibodies Announced Today
Novus Biologicals announced today the release of a new group of Epi-PlusTM antibodies for histone modification testing. Over the past several months, Novus has collaborated with 21st Century Biochemicals, a leading manufacturer of custom antibodies and peptides, to generate the most well validated... - October 12, 2011 - Novus Biologicals
Miami Surgery Practice Offers Discreet New STARR Weight-Loss Treatment
Bariatric surgeon Dr. Enrique Whittwell praises privacy and comfort of new procedure. - October 07, 2011 - TransEnterix
Two New Lamin A + C Antibodies Announced by Novus Biologicals
Novus Biologicals announced today two new Lamin A+C antibodies for use in epigenetic research and for certain cancer research. Lamins and lamin-associated proteins help shape the nucleus and provide a scaffold-type support system for chromosomes and replicating DNA to interact with epigenetic... - October 06, 2011 - Novus Biologicals
FyMed Reinforces Its Drug Development Pipeline with Novel Strategies in Personalized Medicine
FyMed, Inc., a biopharmaceutical company utilizing proprietary methodologies in evidence-based medicine for drug discoveries, recently announced plans for the strategic and operational reinforcements of their drug development pipeline through innovative approaches in personalized medicine. - October 06, 2011 - FyMed Inc
Novus Biologicals Announces New LAMP2 Antibody Made Using SDIX Genomic Antibody Technology™
Novus Biologicals announced today a new LAMP2 antibody (catalog number NBP1-71692) for use as a cell marker in autophagy signaling and cancer research. This LAMP2 antibody was developed using SDIX Genomic Antibody TechnologyTM. LAMP2 is a member of a family of membrane glycoproteins. Specifically,... - October 05, 2011 - Novus Biologicals
New Group of EpiPlus Histone Modification Antibodies Released
Novus Biologicals announced today the release of a new group of Epi-PlusTM antibodies for histone modification testing. Over the past several months, Novus has collaborated with 21st Century Biochemicals, a leading manufacturer of custom antibodies and peptides, to generate the most well validated... - September 30, 2011 - Novus Biologicals
AnaSpec Introduces MOG (35-55), Mouse, Rat Peptide
AnaSpec is pleased to support advances in MS research by providing MOG (35 - 55), mouse, rat, a key peptide that induces severe chronic experimental autoimmune encephalomyelitis in transgenic mice. - September 29, 2011 - AnaSpec, EGT Group
AnaSpec Offers Industry’s First Anti-MOG ELISA Assay Kits
AnaSpec is pleased to be the first in the industry to provide a whole suite of reagents and assay kits for the advancement of MS research. This includes MOG proteins, peptides, antibodies and assay kits. Myelin Oligodendrocyte Glycoprotein (MOG), a protein with a molecular weight of 26- to 28-kDa,... - September 29, 2011 - AnaSpec, EGT Group
New Argentine Distributor Announced by Novus Biologicals
Novus Biologicals announced today a new distributor partnership in Argentina with Migliore Laclaustra, S.R.L. Argentina is a biotechnology leader in Latin America, with more than 80 multinational corporations and local companies currently operating nationally. The combination of a highly qualified... - September 29, 2011 - Novus Biologicals
Launch of Biotechnology Portal cellexis.com – Marketing of Innovative Cell Culture Technology
atech system solutions Ltd. (“atech”) has launched the online service www.cellexis.com for marketing and distribution of innovative products and services in the field of cell culture technology. The online service www.cellexis.com is the portal for distribution of bioreactor systems that are marketed under the name “cellexis one” and services like the delivery of manufacturing processes for cell culture products according to international standards. - September 22, 2011 - atech system solutions Ltd.
New Histone H3 [dimethyl Lys9/phospho Thr6] Antibody Released
Today, Novus added a new Histone H3 [dimethyl Lys9/phospho Thr6] antibody to their growing line of EpiPlusTM histone modification antibodies. Over the past several months, Novus has collaborated with 21st Century Biochemicals, a leading manufacturer of custom antibodies and peptides, to generate... - September 21, 2011 - Novus Biologicals
atech system solutions Develops New Bioreactor Platform for Cell Culture-Based Manufacturing
The atech system solutions Ltd. presents a new generation of bioreactor systems for cell culture-based manufacturing of biopharmaceutical compounds. The new development comprises a platform technology with high performance, safety as well as environmental compatibility and simplification of cell culture-based manufacturing methods. The system platform will be marketed under the brand name “cellexis one.” - September 17, 2011 - atech system solutions Ltd.
Novus Biologicals Announces New NODAL Antibody Made Using SDIX Genomic Antibodiy Technology™
Novus Biologicals announced today a new NODAL antibody (catalog number NBP1-71686) for the study of cancer, angiogenesis and stem cells. This NODAL antibody was made using SDIX Genomic AntibodiesTM (GATTM). This NODAL Antibody (NBP1-71686) serves as an excellent tool for studying stem cell... - September 11, 2011 - Novus Biologicals
AnaSpec Introduces Industry’s First Anti-MOG ELISA Assay Kits
AnaSpec is pleased to be the first in the industry to provide Anti-MOG (Myelin Oligodendrocyte Glycoprotein) ELISA assay kits. The SensoLyte® Anti-Human MOG (1-125) IgG Quantitation ELISA Kit, SensoLyte® Anti-Mouse MOG (1-125) and SensoLyte® Anti-Rat MOG (1-125) IgG ELISA assay kits are... - September 10, 2011 - AnaSpec, EGT Group
AnaSpec Provides Industry’s Largest Collection of Anti-Tau Antibodies
In Alzheimer’s disease (AD), the major pathological hallmarks are β-sheet aggregates of β-amyloid peptides in senile plaques and hyperphosphorylated tau protein in neurofibrillary tangles (NFT).1-2 AnaSpec, a provider of one of the world’s largest collections of β-amyloid... - September 10, 2011 - AnaSpec, EGT Group
Synpromics Teams with Scottish Enterprise to Accelerate Growth
Synpromics Ltd announces the formal support of Scottish Enterprise’s High Growth Start-Up Unit (HGSU). Synpromics intends to leverage this valuable affiliation to help drive growth as the company transitions from a start-up business to an established globally-focused corporation in the future. - August 31, 2011 - Synpromics Ltd
AnaSpec Offers ClearPoint™ β-Amyloid Custom Peptide Synthesis Service
AnaSpec, the world’s largest provider of β-amyloid peptide and Alzheimer’s research reagents, also provides ClearPoint™ β-Amyloid custom peptide synthesis service. ClearPoint™ peptides are AnaSpec’s trademark collection of heavy or stable isotope labeled... - August 24, 2011 - AnaSpec, EGT Group
AnaSpec Offers SensoLyte® 520 TACE Assay Kit
While fluorimetric assay kits for the detection and inhibitor screening of Tumor Necrosis Factor alpha (TNF-α) Converting Enzyme (TACE) currently exist, none of these have been able to take full advantage of the performance provided by long wavelength FRET technologies. AnaSpec’s... - August 24, 2011 - AnaSpec, EGT Group
Novus Releases New Mix-and-Match Pathway Assay Kits
Novus’ new Mix-and-Match Pathway Assay Kits allow for the simultaneous detection of activation states of multiple kinases in a signal pathway on a single multiwell platform. Their kits are designed to be much easier and faster than traditional Western blots (2.5 hour protocol), demonstrate a... - August 18, 2011 - Novus Biologicals